Kezar Life Sciences Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Kezar Life Sciences Inc
TickerKZR
CIK #0001645666
CUSIP49372L100
SectorLife Sciences - Pharmaceutical Preparations
Address4000 Shoreline Court, Suite 300, South San Francisco, CA 94080
Source [EDGAR]
CIK Filing 2011 - 2024
[0001645666] 10-K
[0001645666] 10-Q
[0001645666] 3
[0001645666] 4
[0001645666] 5
[0001645666] 8-K
[0001645666] D
[0001645666] SC 13D
[0001645666] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
ProSight Management LP Kezar Life Sciences Inc [2023-04-21] 5.8
OrbiMed Advisors LLC Kezar Life Sciences Inc [2023-02-14] 5.1
State Street Corp Kezar Life Sciences Inc [2023-02-03] 6.22
BlackRock Inc Kezar Life Sciences Inc [2023-02-03] 6.2
Millennium Management LLC Kezar Life Sciences Inc [2022-06-23] 5.0
Suvretta Capital Management LLC Kezar Life Sciences Inc [2022-06-13] 5.2
BlackRock Inc Kezar Life Sciences Inc [2022-05-09] 4.8
Franklin Resources Inc Kezar Life Sciences Inc [2022-02-04] 5.1
Avidity Partners Management LP Kezar Life Sciences Inc [2022-01-03] 6.6
Logos Global Management LP Kezar Life Sciences Inc [2021-07-29] 5.2
BlackRock Inc Kezar Life Sciences Inc [2021-02-02] 5.4
Morningside Venture Investments Ltd Kezar Life Sciences Inc [2020-02-14] 16.0
Biotechnology Value Fund L P Kezar Life Sciences Inc [2020-02-10] 2.9
Morningside Venture Investments Ltd Kezar Life Sciences Inc [2019-02-14] 12.1
Amgen Inc Kezar Life Sciences Inc [2019-02-08] 9.0
BB Biotech AG Kezar Life Sciences Inc [2019-01-31] 5.1
FMR LLC Kezar Life Sciences Inc [2018-08-10] 0.0
EcoR1 Capital LLC Kezar Life Sciences Inc [2018-07-11] 6.75
Cormorant Asset Management LP Kezar Life Sciences Inc [2018-07-02] 3.6
Form 3/4/5 Filer 2011 - 2024
Morningside Venture Investments Ltd
Kezar Life Sciences, Inc.
Kirk Christopher J.
Belsky Marc
Fowler John Franklin
Henig Noreen
Mordwinkin Nicholas Michael
Klearman Micki
Garner Elizabeth
Berger Franklin M
Cooper Graham K
Wallace Courtney
Kauffman Michael
Dinges Jason
Sommadossi Jean-Pierre
Economides Vassiliki
Equal Talent Investments Ltd
Goel Niti
Steyer Thomas F
Bay City Capital LLC
Aberdare Management Company, LLC
Chen Bihua
Cormorant Global Healthcare Master Fund, LP
Cormorant Global Healthcare GP, LLC
Cormorant Asset Management, LP
A.M. Pappas Life Science Ventures V, LP
PV V CEO Fund, LP
Pappas Capital LLC
AMP&A Management V, LLC
Pappas Arthur M
Chiesi Ventures, Inc.
Chiesi Giacomo
Chiesi Ventures, LP
Amgen Inc
Onyx Therapeutics, Inc.
Omega Fund IV GP, L.P.
Stampacchia Otello
Omega Fund IV G.P. Manager, Ltd.
Lim Richard J.
Omega Fund IV, L.P.
Paster Anne-Mari
Cormorant Private Healthcare Fund I LP
Form 13F Holdings
Firm Period DFND Voting Shares
Suvretta Capital Management LLC [2023-03-31] SOLE 6,887,591.0 6,887,591.0
Avidity Partners Management LP [2023-03-31] SOLE 6,519,400.0 6,519,400.0
OrbiMed Advisors LLC [2023-03-31] DFND 1,339,000.0 5,463,000.0
BlackRock Inc. [2023-03-31] SOLE 4,332,244.0 4,457,990.0
State Street Corp [2023-03-31] DFND 3,174,633.0 3,239,433.0
ProSight Management LP [2023-03-31] SOLE 3,200,000.0 3,200,000.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 2,928,834.0
Millennium Management LLC [2023-03-31] SOLE 2,537,103.0 2,537,103.0
Sphera Funds Management Ltd [2023-03-31] DFND 1,888,228.0 1,888,228.0
Hood River Capital Management LLC [2023-03-31] SOLE 1,324,103.0 1,430,654.0
Franklin Resources Inc [2023-03-31] DFND 1,365,424.0 1,365,424.0
Granahan Investment Management LLC [2023-03-31] SOLE 888,279.0 1,121,336.0
JPMorgan Chase & Co [2023-03-31] DFND 854,384.0 1,087,290.0
Goldman Sachs Group Inc [2023-03-31] DFND 1,082,091.0 1,082,096.0
Citadel Advisors LLC [2023-03-31] DFND 1,073,518.0 1,073,518.0
Geode Capital Management LLC [2023-03-31] DFND 1,034,959.0 1,034,959.0
Northern Trust Corp [2023-03-31] DFND 12,702.0 954,277.0
Caption Management LLC [2023-03-31] SOLE 900,000.0 900,000.0
Ikarian Capital LLC [2023-03-31] SOLE 841,596.0 841,596.0
Barclays PLC [2023-03-31] SOLE 829,034.0 829,034.0
Qiming US Ventures Management LLC [2023-03-31] SOLE 828,711.0 828,711.0
Renaissance Technologies LLC [2023-03-31] SOLE 17,640.0 695,684.0
CHI Advisors LLC [2023-03-31] DFND 689,451.0 689,451.0
Palo Alto Investors LP [2023-03-31] SOLE 656,200.0 656,200.0
Opaleye Management Inc [2023-03-31] SOLE 625,000.0 625,000.0
Two Sigma Investments LP [2023-03-31] SOLE 571,378.0 571,378.0
Nuveen Asset Management LLC [2023-03-31] DFND 551,337.0 551,337.0
Two Sigma Advisers LP [2023-03-31] SOLE 425,000.0 525,600.0
Novo Holdings A/S [2023-03-31] SOLE 465,604.0 465,604.0
Deutsche Bank AG [2023-03-31] DFND 13,327.0 322,583.0
Prev | Page 11 | Next
Terms | Privacy | Guide
tony@aum13f.com